2025 Regular Session • Maryland Legislature
HB529: Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars
Legislative Summary
Requiring certain carriers to post updated, accurate, and complete prescription drug formularies and changes to the formularies in a certain manner on a carrier's website; and requiring certain insurers, nonprofit health service plans, and health maintenance organizations to make certain generic drugs and biosimilars available on a formulary with certain cost sharing.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/22/2025
First Reading Health and Government Operations
House of Delegates
2/3/2025
Hearing 2/13 at 1:00 p.m.
House of Delegates
2/11/2025
Hearing canceled
House of Delegates
2/17/2025
Withdrawn by Sponsor
House of Delegates
Status Information
Current Status
Introduced(1/22/2025)
Chamber
House of Delegates
Sponsors
Democrat: 5
Primary Sponsor
Deni Taveras
Democrat